These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37304004)

  • 21. Medium-Throughput Detection of Hsp90/Cdc37 Protein-Protein Interaction Inhibitors Using a Split
    Siddiqui FA; Parkkola H; Manoharan GB; Abankwa D
    SLAS Discov; 2020 Feb; 25(2):195-206. PubMed ID: 31662027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of celastrol to inhibit hsp90 and cdc37 interaction.
    Zhang T; Li Y; Yu Y; Zou P; Jiang Y; Sun D
    J Biol Chem; 2009 Dec; 284(51):35381-9. PubMed ID: 19858214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hsp90 modulates human sperm capacitation via the Erk1/2 and p38 MAPK signaling pathways.
    Sun P; Wang Y; Gao T; Li K; Zheng D; Liu A; Ni Y
    Reprod Biol Endocrinol; 2021 Mar; 19(1):39. PubMed ID: 33663544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.
    Wang L; Li L; Zhou ZH; Jiang ZY; You QD; Xu XL
    Eur J Med Chem; 2017 Aug; 136():63-73. PubMed ID: 28482218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
    Gaiser AM; Kretzschmar A; Richter K
    J Biol Chem; 2010 Dec; 285(52):40921-32. PubMed ID: 20880838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.
    Gray PJ; Stevenson MA; Calderwood SK
    Cancer Res; 2007 Dec; 67(24):11942-50. PubMed ID: 18089825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37.
    Roiniotis J; Masendycz P; Ho S; Scholz GM
    Biochemistry; 2005 May; 44(17):6662-9. PubMed ID: 15850399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening.
    He J; Niu X; Hu C; Zhang H; Guo Y; Ge Y; Wang G; Jiang Y
    Protein Expr Purif; 2013 Nov; 92(1):119-27. PubMed ID: 24056254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginsenoside Rg5 enhances the radiosensitivity of lung adenocarcinoma via reducing HSP90-CDC37 interaction and promoting client protein degradation.
    Bai H; Lyu J; Nie X; Kuang H; Liang L; Jia H; Zhou S; Li C; Li T
    J Pharm Anal; 2023 Nov; 13(11):1296-1308. PubMed ID: 38174116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).
    Roe SM; Ali MM; Meyer P; Vaughan CK; Panaretou B; Piper PW; Prodromou C; Pearl LH
    Cell; 2004 Jan; 116(1):87-98. PubMed ID: 14718169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The co-chaperone Cdc37 regulates the rabies virus phosphoprotein stability by targeting to Hsp90AA1 machinery.
    Xu Y; Liu F; Liu J; Wang D; Yan Y; Ji S; Zan J; Zhou J
    Sci Rep; 2016 Jun; 6():27123. PubMed ID: 27251758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
    Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
    J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors.
    Smith JR; Clarke PA; de Billy E; Workman P
    Oncogene; 2009 Jan; 28(2):157-69. PubMed ID: 18931700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A client-binding site of Cdc37.
    Terasawa K; Minami Y
    FEBS J; 2005 Sep; 272(18):4684-90. PubMed ID: 16156789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of Disruptors of the Hsp90-Cdc37 Interface.
    D'Annessa I; Hurwitz N; Pirota V; Beretta GL; Tinelli S; Woodford M; Freccero M; Mollapour M; Zaffaroni N; Wolfson H; Colombo G
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31952296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
    Zhang H; Wu W; Du Y; Santos SJ; Conrad SE; Watson JT; Grammatikakis N; Gallo KA
    J Biol Chem; 2004 May; 279(19):19457-63. PubMed ID: 15001580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural bioinformatics and protein docking analysis of the molecular chaperone-kinase interactions: towards allosteric inhibition of protein kinases by targeting the hsp90-cdc37 chaperone machinery.
    Lawless N; Blacklock K; Berrigan E; Verkhivker G
    Pharmaceuticals (Basel); 2013 Nov; 6(11):1407-28. PubMed ID: 24287464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function.
    Wang L; Li L; Gu K; Xu XL; Sun Y; You QD
    Curr Drug Targets; 2017; 18(13):1572-1585. PubMed ID: 27231111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer.
    Wang L; Jiang J; Zhang L; Zhang Q; Zhou J; Li L; Xu X; You Q
    J Med Chem; 2020 Feb; 63(3):1281-1297. PubMed ID: 31935086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of Harc, a novel Hsp90-associating relative of Cdc37.
    Scholz GM; Cartledge K; Hall NE
    J Biol Chem; 2001 Aug; 276(33):30971-9. PubMed ID: 11413142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.